ArticleFrontiers in oncology2021

Plasma Exosome-Derived Sentrin SUMO-Specific Protease 1: A Prognostic Biomarker in Patients With Osteosarcoma.

Li Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.